UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Link to "El español"
Link to "Apunt" Video
Link to "Innospain"
Link to "La Sexta"
Link to "Cadena Ser"
Link to "News Medical"

Related posts
CARE-ECGI: Transforming cardiac pacing through noninvasive mapping and AI

At Corify Care, we are proud to coordinate CARE-ECGI, a national R&D project focused on advancing noninvasive mapping to support cardiac pacing...

Read More »
Now You Can See How Corify’s ECGI Technology Works — In Real Time

Our work has been featured in the Journal of Visualized Experiments (JoVE) — including a full video that shows, step by step,...

Read More »
Corify technology supports new AF stratification model published in JCE

Corify technology supports new AF stratification model published in JCE The Journal of Cardiovascular Electrophysiology has just published results from the STRATIFY...

Read More »